Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 495,282 shares at $15.00 ($7.4M) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($7.4M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $332K | — | Filing → |